AAP
30
3
HBI
50
-2
EMR
50
2
SLB
46
2
MTCH
50
19
LOW
50
4
KMI
69
4
O
35
5
ILMN
64
4
CINF
37
6
A
47
6
PNC
52
-3
UAL
80
-3
STX
52
2
SEE
45
-4
C
50
-4
KEY
33
-4
F
40
5
DTE
47
2
ABBV
57
-2
AAP
30
3
HBI
50
-2
EMR
50
2
SLB
46
2
MTCH
50
19
LOW
50
4
KMI
69
4
O
35
5
ILMN
64
4
CINF
37
6
A
47
6
PNC
52
-3
UAL
80
-3
STX
52
2
SEE
45
-4
C
50
-4
KEY
33
-4
F
40
5
DTE
47
2
ABBV
57
-2
Financhill
Back

AnaptysBio 10K Form

Sell
1

ANAB
AnaptysBio

Last Price:
19.45
Seasonality Move:
1.79%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-02 10Q ANAB/AnaptysBio Quarterly
2023-08-07 10Q ANAB/AnaptysBio Quarterly
2023-05-11 10Q ANAB/AnaptysBio Quarterly
2022-11-08 10Q ANAB/AnaptysBio Quarterly
2022-08-08 10Q ANAB/AnaptysBio Quarterly
2022-05-04 10Q ANAB/AnaptysBio Quarterly

Receive ANAB News And Ratings

See the #1 stock for the next 7 days that we like better than ANAB

ANAB Financial Statistics

Sales & Book Value

Annual Sales: $17.16M
Cash Flow: $-21.36M
Price / Cash Flow: 0
Annual Sales: $0.36
Price / Book: 55.4

Profitability

EPS (TTM): -6.35000
Net Income (TTM): $-170.12M
Gross Margin: $5.48M
Return on Equity: -205.16%
Return on Assets: -37.14%

AnaptysBio Earnings Forecast

Key AnaptysBio Financial Ratios

  • The Gross Profit Margin over the past 1 years for ANAB is 100.00%.
  • The Selling, General & Administrative Expenses for ANAB have been equal to 244.48% of Gross Profit Margin.
  • The Research & Development expenses have been 771.01% of Revenue.
  • The Interest Expense is -11.05% of Operating Income.
  • The Net Earning history of ANAB is -953.66% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 3 years.

AnaptysBio Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ANAB
CUSIP: 032724
Website: anaptysbio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 9.09
Quick Ratio: 8.9

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ANAB Technical Analysis vs Fundamental Analysis

Sell
1
AnaptysBio (ANAB) is a Sell

Is AnaptysBio a Buy or a Sell?

  • AnaptysBio stock is rated a Sell
    The current AnaptysBio [ANAB] share price is $19.94. The Score for ANAB is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.